Log in to your Inderes Free account to see all free content on this page.
Abera Bioscience
6.50 SEK
-2.26 %
Less than 1K followers
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-2.26 %
+8.33 %
-19.75 %
-18.24 %
+44.12 %
+54.39 %
+32.52 %
-
-41.18 %
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Read moreMarket cap
121.09M SEK
Turnover
65 SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2.
2026
Annual report '25